
    
      This study is designed to evaluate 6 month in-stent late lumen loss of the 1) Corio™
      pimecrolimus-eluting coronary stent system and the 2) SymBio™ dual
      pimecrolimus/paclitaxel-eluting coronary stent system compared to the CoStar™
      Paclitaxel-Eluting Coronary Stent System control arm.
    
  